Additional file 1 of Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: a Mendelian randomization study

Additional file 1: Table S1. [STROBE-MR checklist of Mendelian randomization study]. Table S2. [Characteristics of the GWAS summary data of exposures]. Table S3. [Removed SNPs and related traits]. Table S4. [Cancer GWAS data information in UK Biobank]. Table S5. [Cancer GWAS data information in FinnGen]. Table S6. [Cancer GWAS data information in other consortiums]. Table S7. [SNPs used as instrumental variable for inflammatory bowel disease]. Table S8. [Related traits of SNPs for inflammatory bowel disease]. Table S9. [SNPs used as instrumental variable for Crohn’s disease]. Table S10. [Related traits of SNPs for Crohn’s disease]. Table S11. [SNPs used as instrumental variable for ulcerative colitis]. Table S12. [Related traits of SNPs for ulcerative colitis]. Table S13. [Sensitivity analyses in UK Biobank]. Table S14. [Causal effects of inflammatory bowel disease on 32 site-specific extracolonic cancer risk in FinnGen using IVW method]. Table S15. [Sensitivity analyses in FinnGen]. Table S16. [Causal effects of inflammatory bowel disease on 32 site-specific extracolonic cancer risk in other consortiums using IVW method]. Table S17. [Sensitivity analyses in other consortiums]. Table S18. [Meta-analysis results from three source of MR analysis].